| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| LAE-102 | LAE-102 | Phase 2 Clinical | Solid tumours; Metabolic Dysfunction-Associated Steatotic Liver Disease; Carcinoma, Non-Small-Cell Lung | Details | |
| LAE-123 | LAE-123 | Details |

BettinastraBe 30, 60325 Frankfurt am Main



